Next-Generation Sequencing
An NGS-Based PGT Approach for Genetic Testing in IVF
Modern fertility care is no longer only about achieving pregnancy—it is also about improving the likelihood of a healthy pregnancy by understanding embryo genetics before transfer. One of the most advanced tools used today is Next-Generation Sequencing (NGS), a high-resolution technology that supports Preimplantation Genetic Testing (PGT) during IVF.
Across international fertility travel, many intended parents actively search for solutions such as Cyprus IVF, IVF in North Cyprus (TRNC), genetic testing IVF, PGT-A Cyprus, and NGS embryo screening. Cyprus has become a frequent destination in these searches due to its strong IVF experience, international patient workflows, and access to modern embryo genetics strategies in appropriate cases.
This guide explains what NGS is, how it is used in PGT, who may benefit from NGS-based embryo screening, and how the process typically fits into a Cyprus IVF treatment plan.
What Is NGS (Next-Generation Sequencing)?
Next-Generation Sequencing (NGS) is a DNA analysis method capable of reading and evaluating genetic material with high depth and precision. In the IVF setting, NGS is most often used to analyze embryo biopsy samples as part of PGT, helping clinicians identify embryos that are more likely to have a normal chromosomal profile (or to be free of a targeted genetic condition, depending on the test type).
NGS does not “create” healthy embryos—rather, it helps classify embryos based on genetic findings so that embryo selection and transfer planning can be more informed.
In the context of Cyprus IVF, NGS-based testing is usually discussed when there are specific risk factors or clinical indications, not as an automatic step for every patient.
How NGS Supports PGT in IVF
PGT is an umbrella term that includes several types of embryo genetic testing. NGS is commonly used as the technology platform to analyze the biopsy sample.
1) PGT-A (Aneuploidy Screening)
PGT-A evaluates embryos for chromosomal number abnormalities (aneuploidy), such as:
-
missing chromosomes (monosomy)
-
extra chromosomes (trisomy)
-
certain mosaic patterns (depending on reporting thresholds and laboratory policies)
PGT-A is commonly discussed in searches like:
-
“PGT-A Cyprus”
-
“NGS PGT-A North Cyprus”
-
“IVF genetic testing Cyprus”
2) PGT-M (Single-Gene Testing)
PGT-M focuses on a specific inherited condition known to exist in the family (for example, certain single-gene disorders). It requires advanced planning and often involves building a family-specific testing strategy.
3) PGT-SR (Structural Rearrangement Testing)
PGT-SR is considered when one partner carries a balanced chromosomal rearrangement (such as a translocation). The goal is to identify embryos more likely to have a balanced/normal chromosomal structure.
In many Cyprus IVF clinic workflows, patients may hear these terms as part of a broader conversation about genetic risk, recurrent loss, or repeated IVF failure.
Why Patients Consider NGS-Based PGT in Cyprus IVF
People researching IVF in Cyprus or IVF in North Cyprus (TRNC) often compare destinations based on laboratory capabilities, treatment coordination, and how efficiently complex steps can be planned. When NGS-based PGT is medically appropriate, some practical reasons Cyprus IVF is frequently considered include:
Advanced IVF Laboratory Pathways
NGS-based PGT relies on:
-
careful embryo culture (often to blastocyst stage)
-
biopsy technique expertise
-
secure sample handling and traceability
-
coordinated timing for freezing and transfer planning
Travel-Friendly Planning
International patients commonly search:
-
“Cyprus IVF treatment plan”
-
“frozen embryo transfer Cyprus”
-
“IVF abroad North Cyprus”
because many steps (screening tests, monitoring, medication scheduling) can sometimes be partially coordinated before travel, depending on individual circumstances.
Integration with Other IVF Options
Patients who explore Cyprus IVF may also be comparing:
-
egg donation Cyprus
-
sperm donation Cyprus
-
embryo donation North Cyprus
-
advanced male factor methods (e.g., sperm selection techniques)
-
frozen embryo transfer (FET) pathways
When PGT is used, embryos are typically frozen after biopsy, and transfer happens later in a controlled cycle.
Who May Benefit from NGS-Based PGT?
NGS-based PGT is not automatically “better” for everyone. It is most often considered when risk factors suggest embryo genetics could be a major limiting factor. Common scenarios include:
-
Advanced maternal age (often discussed around 37–38+)
-
Recurrent pregnancy loss
-
Repeated IVF failure, especially if good-quality embryos were transferred without implantation
-
Known genetic condition in one or both partners (PGT-M consideration)
-
Known chromosomal rearrangement (PGT-SR consideration)
-
Severe male factor infertility, especially when DNA damage concerns exist (assessment depends on the case)
-
Desire for more strategic embryo selection when multiple embryos are available
A careful, individualized review is essential because testing can also reduce the number of embryos considered suitable for transfer, and not every patient will gain the same advantage.
Step-by-Step: NGS-Based PGT Within a Cyprus IVF Cycle
While protocols differ by clinic, a typical structure looks like this:
1) Consultation and Testing Strategy
The medical team reviews:
-
reproductive history
-
ultrasound and hormone tests (AMH, FSH, etc.)
-
semen analysis and any advanced male factor testing
-
miscarriage history and prior IVF outcomes
-
genetic background (family history, known variants, karyotype results if relevant)
Then they determine whether the plan is:
-
PGT-A, PGT-M, PGT-SR, or a combined approach
-
and whether NGS is the appropriate platform for analysis
2) IVF / ICSI and Embryo Culture
Eggs are retrieved and fertilized using IVF or ICSI. Embryos are monitored in the lab, often aiming for day 5 blastocyst development when biopsy is planned.
3) Embryo Biopsy (Typically Trophectoderm Biopsy)
At blastocyst stage, a few cells are taken from the outer layer (trophectoderm), which later forms placental tissue. The embryo itself is then typically cryopreserved (frozen) while genetic testing is performed.
4) NGS Analysis
The biopsy sample is processed and analyzed using NGS. Depending on the test type:
-
PGT-A focuses on chromosomal copy number patterns
-
PGT-M targets a specific known genetic condition
-
PGT-SR evaluates chromosomal structural balance risks
The report commonly classifies embryos into categories such as genetically suitable/unsuitable for transfer, with additional notes depending on laboratory reporting policies (including how mosaic findings are handled).
5) Frozen Embryo Transfer (FET) Planning
Once results are available:
-
the uterus is prepared in a controlled cycle (often with estrogen/progesterone support)
-
the selected embryo is thawed and transferred
-
pregnancy testing and follow-up are scheduled
For many international patients searching Cyprus IVF, this frozen-transfer approach can also simplify timing and travel because the transfer cycle can be planned around predictable dates.
Accuracy, Limitations, and Important Considerations
NGS-based PGT is powerful, but it has boundaries that patients should understand clearly:
NGS-Based PGT Does Not Guarantee Pregnancy
Genetic screening can help identify embryos with more favorable genetic findings, but implantation and pregnancy also depend on:
-
uterine factors (lining development, cavity health)
-
embryo biology beyond genetics
-
immune, hormonal, and metabolic health factors
-
treatment timing and protocol fit
Mosaicism and Reporting Differences
Some embryos may show mosaic patterns (a mix of normal and abnormal cell lines). How mosaicism is reported and how decisions are made varies between laboratories and medical policies. This topic should be discussed carefully because it can directly influence embryo prioritization.
Biopsy and Freezing Are Highly Technical Steps
Embryo biopsy and vitrification (rapid freezing) are widely used in modern IVF, but they still require consistent laboratory performance. Even with best practices, no procedure is “zero risk.”
You May End Up with Fewer Transferable Embryos
A common emotional challenge is that after testing, fewer embryos may be classified as suitable—or sometimes none. This possibility should be part of the decision-making discussion before starting.
Frequently Asked Questions
Is NGS-based PGT the same as PGD?
The term PGD was historically used for diagnosing specific genetic diseases. Today, many clinics use PGT terminology:
-
PGT-A (aneuploidy)
-
PGT-M (single gene)
-
PGT-SR (structural rearrangements)
People searching online may still use “PGD Cyprus” or “PGD North Cyprus,” but the modern umbrella term is typically PGT.
Does NGS testing help with repeated IVF failure?
It can help in selected cases, especially when embryo aneuploidy is suspected as a key barrier. However, repeated failure can also be linked to uterine, hormonal, immunologic, or procedural factors—so the workup should be comprehensive.
Can NGS detect every possible health issue?
No. NGS-based PGT is designed for specific categories of genetic evaluation depending on the test. It does not screen for every disease, every developmental outcome, or every pregnancy complication.
Conclusion: NGS-Based PGT as a Strategic Tool in Cyprus IVF
Next-Generation Sequencing (NGS) has become one of the most advanced methods used in embryo genetic screening, supporting informed embryo selection within IVF. In appropriate clinical scenarios—such as advanced maternal age, recurrent miscarriage, repeated IVF failure, or known genetic risks—NGS-based PGT can add an important layer of insight.
For patients exploring Cyprus IVF, IVF in North Cyprus (TRNC), and genetic testing in IVF, the best approach is a personalized evaluation that weighs potential benefits against limitations, timelines, and embryo availability. When used for the right reasons and with realistic expectations, NGS-based PGT can be a valuable part of a modern fertility strategy.